Detection of patent foramen ovale in patients with ischemic stroke on prospective ECG-gated cardiac CT compared to transthoracic echocardiography

Patent foramen ovale (PFO) is present in approximately a quarter of the general population, but is considerably more common in patients with cryptogenic stroke [1‐3]. PFO closure is indicated in patients younger than 60 years with cryptogenic stroke to reduce stroke recurrence. Although transoesophageal echocardiography (TEE) has been considered the gold standard for diagnosis of PFO, up to one third of stroke patients cannot undergo TEE due to the severity of their stroke, dysphagia, excessive gag reflexes or refusal. Moreover, use of sedation makes the performance of the Valsalva maneuver during TEE more difficult [4, 5]. Previous studies have suggested that transthoracic echocardiography with agitated saline contrast (cTTE) has a similar detection rate for PFO compared to TEE when performed by skilled operators [6, 7]. Therefore, cTTE is most commonly used to screen for PFO [8, 9].

Cardiac CT acquired during the acute stroke imaging protocol is an emerging alternative to TTE to screen for cardioembolism, and a recent study showed that cardiac CT has a higher diagnostic yield than TTE for the detection of high-risk sources of embolism [10]. Currently, the diagnostic accuracy of cardiac CT acquired during the acute stroke imaging protocol to detect PFO is unclear. We, therefore, aimed to assess the sensitivity, specificity, positive predictive value, and negative predictive value of prospective ECG-gated cardiac CT in acute ischemic stroke patients to determine whether it is a suitable screening method for the detection of PFO.

This was a substudy of the Mind the Heart study, a prospective single-center cohort study in which the diagnostic yield of cardiac CT acquired during the acute stroke work-up was evaluated. Between 2018 and 2020, we included consecutive adult patients with acute ischemic stroke who were potentially eligible for reperfusion therapy (intravenous thrombolysis [IVT] or endovascular treatment [EVT]) at the time of admission (i.e., patients with acute onset neurological symptoms that developed less than 24 h ago). Patients who underwent prospective ECG-gated cardiac CT were triggered to scan during end diastole as part of the initial stroke imaging protocol. Cardiac CT was acquired immediately following non-contrast-enhanced CT of the brain, CT perfusion, and non-gated CT-angiography of the aortic arch, cervical and intracranial arteries. Patients also underwent routine stroke work-up, including TTE. TEE was not routinely performed. Additional details of the study have been published [10]. For the current study, we included all patients who underwent TTE with agitated saline contrast, which was indicated in patients < 60 years in the Mind the Heart study.

Details of the imaging protocol have been published [11]. Presence of PFO was assessed on CT and cTTE according to predefined criteria [11]. On CT, a PFO was defined as a crypt-shaped contrast jet from the left atrium to the right atrium toward the vena cava, or an atrium septum discontinuity [12, 13]. All CT images were systematically assessed by a cardiac radiologist. On cTTE, a PFO was defined as the appearance of microbubbles in the left atrium within 3–6 cardiac beats after opacification of the right atrium [8]. All images were assessed by a cardiologist. During assessment, the cardiac radiologists and cardiologists were blinded to each other’s results. In case of indeterminate results on cardiac CT or cTTE (i.e., due to insufficient image quality), PFO was scored as not being present.

Of 452 patients included in the Mind the Heart study, 92 (20%) patients were younger than 60 years. Of these, 59 (64%) underwent cTTE and were included in the current study (Fig. 1).

Median age was 54 (interquartile range [IQR] 49–57) years and 41 (70%) were male (Table 1). In total, 33/59 (56%) patients had cryptogenic stroke and their median Risk of Paradoxical Embolism score was 6 (IQR 6–7). Stroke etiology in the remaining patients was large-artery atherosclerosis in five, cardioembolism in eight, small vessel disease in seven, and other determined in six. There were four indeterminate results on CT, all due to low scan quality, and none on cTTE. Median time difference between cardiac CT and cTTE was 2 (IQR 0–16) days.

Cardiac CT detected a PFO in 5/59 (8%) patients, 3 of which were confirmed on cTTE (Table 2, Figs. 2, 3). cTTE detected a PFO in 12/59 (20%) patients. This resulted in a sensitivity of cardiac CT of 25% (95% confidence interval [95% CI] 5–57%) and specificity of 96% (95% CI 85–99%, Table 3). The positive and negative predictive values were 59% (95% CI 14–95) and 84% (95% CI 71–92), respectively.

Both cardiac CT and cTTE did not detect an atrial septal aneurysm (ASA) in any of the patients with a PFO. One patient with a PFO had a jump-rope interatrial septum detected on echocardiography, though this did not fulfill the criteria for presence of an atrial septal aneurysm (protrusion of > 10 mm beyond the plane of the atrial septum).

Of the 12 patients with a PFO on cTTE, 3 had another identifiable cause of their stroke. Of the remaining nine patients, two did not have a large interatrial shunt according to the CLOSE criteria (< 30 bubbles), meaning that 7 PFO’s fulfilled the criteria of the CLOSE study. Cardiac CT detected a PFO in two of seven of these patients, indicating a similar sensitivity (28%) in this subgroup of patients with a PFO. Results were similar when also including the five patients of 60 years and older who underwent cTTE (supplemental material Tables 1, 2).

Three patients underwent TEE and a PFO was detected on TEE in two of them. Indications for TEE were: assessment if the PFO was eligible for device closure in one, confirmation of PFO detected on cTTE in one, and assessment of the left atrial appendage in the third. No patients underwent transcranial Doppler (TCD) for detection of right–left shunting.

In this study, prospective ECG-gated cardiac CT acquired during the acute stroke protocol had a low sensitivity for the detection of PFO in patients with acute ischemic stroke. These data suggest that cardiac CT fails to detect the majority of PFO’s.

The low sensitivity of prospective ECG-gated cardiac CT may be explained by several reasons. First, detection of PFO on CT and TTE is based on different principles. cTTE is used to identify a temporarily right-to-left shunt during the Valsalva maneuver which results in a brief moment of right atrial pressure exceeding the left atrial pressure. In contrast, CT is used to diagnose PFO detecting a left-to-right shunting during rest. The shunt flow through a PFO is determined by differences in pressure between the left and right atrium. Pressure differences between the left atrium and right atrium are the largest during end systole, isovolumetric relaxation, and early diastole [15], while cardiac CT was triggered to scan only during end diastole in our cohort. As such, the false negative findings on CT could be due to equivalent pressures in the left and right atrium at the moment of image acquisition. Moreover, left-to-right shunting may not occur in all patients with a PFO [16‐18], indicating that these PFO’s may be undetectable on cardiac CT. Furthermore, the applied single-phase prospective ECG-gated cardiac CT acquisition does not allow for dynamic assessment of the heart since only a single phase of the cardiac cycle is scanned, which may further hamper detection of PFO’s. Previous studies compared retrospective ECG-gated cardiac CT, in which the heart is scanned throughout the entire cardiac cycle and images are reconstructed retrospectively, with TEE for the detection of PFO and these studies reported a higher sensitivity and specificity of cardiac CT [15, 19]. However, since more radiation is required for retrospective gated cardiac CT, we decided on prospective ECG gating for our acute stroke imaging protocol.

Although studies have shown that TEE and TCD have a higher diagnostic accuracy than TTE [20], TTE is often the first-line screening method for PFO [8]. Previous studies comparing TEE with TTE and TCD for the detection of PFO reported reasonable sensitivity and specificity for TTE, with the discrepancy between the modalities mainly being driven by false negatives on TTE with very few false positives [21]. Hence, it is likely that if we would have compared prospective gated cardiac CT to TEE or TCD, rather than TTE, the sensitivity of cardiac CT would only have been lower.

A previous meta-analysis of individual patient data of six randomized controlled trials showed that the PFO-Associated Stroke Causal Likelihood (PASCAL) classification performs best in identifying patients who may benefit most from PFO closure [22]. The PASCAL score combines the Risk of Paradoxical Embolism (RoPE) score with additional assessment of high-risk features, either large size of the shunt or presence of atrial septum aneurysm. Although the presence of atrial septum aneurysm can be assessed on prospective ECG-gated cardiac CT, it does not allow for reliable quantification of PFO size. Moreover, cardiac CT detected only 22–73% of atrial septum aneurysms which were diagnosed on echocardiography in previous studies [23, 24]. This provides another argument that if prospective ECG-gated cardiac CT is implemented as a screening method for cardioembolic sources, additional echocardiography is required in patients in whom detection of a PFO has therapeutic consequences.

We were unable to assess the sensitivity of cardiac CT acquired during the acute phase for detection of atrial septal defects (ASD), since none were diagnosed on cTTE. On echocardiography, ASD is diagnosed by detecting a left-to-right shunt. On CT, PFO is differentiated from ASD based on the direction of the left-to-right contrast agent jet, which is toward the vena cava inferior for PFO and perpendicular to the atrial septum for ASD. A previous study showed that retrospective ECG-gated cardiac CT detected all three ASD’s which were diagnosed on TEE [24]. More data are needed to determine whether cardiac CT during the stroke imaging protocol is a suitable screening technique for the detection of ASD.

Prospective gated cardiac CT has a higher diagnostic yield for various high-risk structural sources of embolism than TTE, such as cardiac thrombi [10]. However, our findings suggest that if prospective cardiac CT is implemented in the initial stroke imaging protocol to screen for cardiac structural sources of embolism, echocardiography or TCD will remain essential for PFO detection.

This study has several limitations. First, the sample size is limited, although it is one of the largest studies to date comparing prospective cardiac CT acquired in the acute phase of ischemic stroke to TTE with agitated saline for the detection of PFO. Second, we did not compare CT with TEE or TCD which have a higher diagnostic yield for PFO detection. Third, this was a single-center study, which limits the generalizability of the results. Finally, we cannot exclude that selection bias occurred since 33 patients in our cohort who were younger than 60 years did not undergo cTTE.

Prospective ECG-gated cardiac CT acquired during the acute stroke imaging protocol does not appear to be a suitable screening method for PFO due to its low sensitivity. Our data suggest that if cardiac CT is used as a first-line screening method for cardioembolism, additional echocardiography remains indicated in young patients with cryptogenic stroke, in whom PFO detection would have therapeutic consequences. These results need to be confirmed in larger cohorts.